Hockhua herb tea has been approved by the FDA for use in menopausal women

Hockhuas herbal tea has a number of benefits for menopausal patients, including reducing pain and stiffness in osteoarthritis.

However, its approval by the Food and Drug Administration for use as a treatment in women has been met with concern.

The herbal tea is available in a range of flavours and formulations, including tonics, teas and creams.

In addition to reducing pain, the herbal tea also has anti-inflammatory properties.

“The new Hockhanas herbal Tea, is the first herbal tea to be approved by FDA for the treatment of osteoarthropathy in women,” said Dr. Michael T. B. Coyle, chief scientific officer at Hockua, the company that makes the tea.

“We are excited to be able to provide a safe and effective alternative to prescription medications for the majority of women suffering from osteo arthropathy.”

Hockhua is currently undergoing a pilot study to test its herbal tea in women with osteoarcenial pain.

The herbal tea was approved for the use of women with the disease by the US Food and Drugs Administration last month.

While Hockhans herbal tea may offer an alternative to some of the more commonly prescribed medications in osteoporosis, it may not offer the same level of efficacy in the long-term.

“Hockhan is one of the first herbs to be evaluated for use for osteo-arthritis,” said B.B. Glynn, the director of the University of New South Wales Osteoporotic Disease Center.

“If this tea becomes a treatment, we would be concerned about its long- term effects on bone density and the possibility that it could contribute to osteoarticular atrophy.

More to come on Hockhai herbal tea.